Wybrane najnowsze publikacje naszych autorów

• Schmidt V., Ziemlinska E., Obrebski T., Gomes J.P., Zurawska-Plaksej E, Cendrowski J., Palmfeldt J., Hempstead B.L., Willnow T.E., Malik A.R.: Astrocytes distress triggers brain pathology through induction of δ secretase in a murine model of Alzheimer's disease. Nature Communications. 2025;16(1):9653. DOI: 10.1038/s41467-025-65536-y, IF: 15,7
• Lowery M.A., Wyrwicz L.S., Oh D.Y., Shiu K.K., Yañez P., Bai Y., Ryu M.H., Lee J., Rivera F., Alves G.V., Garrido M., Fernández M.G., Li J., Çil T., Cruz F.M., Qin S., Guan Y., Valderrama A., Bordia S., Rha S.Y.: First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial. European Journal of Cancer. 2025;231:115807. DOI: 10.1016/j.ejca.2025.115807, IF: 7,1
• Molina-Cerrillo J., Roviello G., Bourlon M.T., Studentova H., Fiala O., Cerbone L., Kucharz J., Ansari J., Zeppellini A., Taha T., Buti S., Ürün Y., Scagliarini S., Li H., Sunela K., Park S.H., Rizzo M., Zgura A., Chiari R., Seront E., Catalano M., Ghosn M., Filosa A., Soares A., Massari F., Monteiro F.S.M., Grande E., Porta C., Bracarda S., Santoni M.: Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study). International Journal of Cancer. 2025. DOI: 10.1002/ijc.70228, IF: 4,7
• Piątek S., Dańska-Bidzińska A., Derlatka P., Szymanowski B., Duchnowska R., Zielińska A., Sawicka N., Gorzeń A., Michalski W., Bidziński M.: Significance of CA125 Monitoring during Maintenance Treatment with Poly(ADP-Ribose) Polymerase Inhibitor in Ovarian Cancer after First-Line Chemotherapy: Multicenter, Observational Study. Oncology Research. 2025;33(11):3405-3416. DOI: 10.32604/or.2025.068609, IF: 4,1
• Kunicki J., Buchalska B., Maksymowicz M., Baluszek S., Mandat T.: Endoscopic endonasal resection of giant pituitary adenomas - case series from the referral pituitary center. Pituitary. 2025;28(6):122. DOI: 10.1007/s11102-025-01596-z, IF: 3,4